Table 2 P-EVs based clinical trials
From: Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges
ID no. | Phase | EVs source | Loaded agent | Condition | Administration | Status |
|---|---|---|---|---|---|---|
NCT01294072 | I | Plants | Curcumin | Colon cancer | Oral Tablets | Active, not recruiting |
NCT03493984 | Preliminary Clinical Trial | Ginger Aloe | Not determined | Insulin-related conditions Chronic inflammation in patients | – | Recruiting |
NCT01668849 | I | Grapes | Not determined | Oral Mucositis | Dietary Supplement oral, daily for 35Â days | Active, not recruiting |